Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell–Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8+ CTL Responses and Antitumor …

Y Xie, O Bai, H Zhang, W Li, J Xiang - Cancer Biotherapy and …, 2010 - liebertpub.com
Exosomes (EXOs) derived from tumor cells have been used to stimulate antitumor immune
responses. It has been demonstrated that EXO released by tumor cells engineered to …
被引用次数：36 相关文章

Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity

Y Xie, O Bai, H Zhang, W Li… - Cancer biotherapy & …, 2010 - pubmed.ncbi.nlm.nih.gov
Exosomes (EXOs) derived from tumor cells have been used to stimulate antitumor immune
responses. It has been demonstrated that EXO released by tumor cells engineered to …

Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.

Y Xie, O Bai, H Zhang, W Li, J Xiang - Cancer Biotherapy & …, 2010 - europepmc.org
Exosomes (EXOs) derived from tumor cells have been used to stimulate antitumor immune
responses. It has been demonstrated that EXO released by tumor cells engineered to …

Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific [CD8. sup.+] CTL responses and antitumor immunity

Y Xie, O Bai, H Zhang, W Li, J Xiang - Cancer Biotherapy & …, 2010 - go.gale.com
Exosomes (EXOs) derived from tumor cells have been used to stimulate antitumor immune
responses. It has been demonstrated that EXO released by tumor cells engineered to …

Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell-Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8+ CTL Responses and Antitumor …

Y Xie, O Bai, H Zhang, W Li… - Cancer Biotherapy & …, 2010 - search.proquest.com
Exosomes (EXOs) derived from tumor cells have been used to stimulate antitumor immune
responses. It has been demonstrated that EXO released by tumor cells engineered to …

[引用][C] Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell-Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8+ CTL Responses and Antitumor …

Y XIE, OU BAI, H ZHANG, WEI LI, JIM XIANG - Cancer biotherapy & …, 2010 - Liebert